MindWalk Holdings Corp. (HYFT)
NASDAQ: HYFT · Real-Time Price · USD
1.867
+0.017 (0.94%)
Sep 9, 2025, 12:59 PM - Market open
Company Description
MindWalk Holdings Corp. operates as an AI-driven biotherapeutic research, technology, and scientifically robust life science company.
It discovers and develops customized and novel antibodies by generating proprietary and patented processes, procedures, and innovative approaches to antibody discovery, development, and production.
The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025.
The company was incorporated in 1983 and is headquartered in Austin, Texas.
MindWalk Holdings Corp.
Country | United States |
Founded | 1983 |
IPO Date | Jan 3, 2017 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 102 |
CEO | Jennifer Bath |
Contact Details
Address: Industrious 823 Congress Ave, Suite 300 Austin, Texas 78701 United States | |
Phone | 800-620-4187 |
Website | ipatherapeutics.com |
Stock Details
Ticker Symbol | HYFT |
Exchange | NASDAQ |
Fiscal Year | May - April |
Reporting Currency | CAD |
CIK Code | 0001715925 |
ISIN Number | CA45257F2008 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Dr. Jennifer Lynne Bath Ph.D. | Chief Executive Officer, President and Non-Independent Director |
Joseph Scheffler | Interim Chief Financial Officer |
Kari Graber | Vice President of Commercial Services |
Dirk Van Hyfte M.D., Ph.D. | Chief Technology Officer |
Frederic Chabot | Head of Corporate Development |
Ingrid Brands M.D., Ph.D. | Chief Innovation and Strategy Officer |
Lori Anderson | Vice President of Brand Marketing and Creative |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Sep 3, 2025 | 6-K | Report of foreign issuer |
Sep 2, 2025 | 6-K | Report of foreign issuer |
Aug 27, 2025 | 6-K | Report of foreign issuer |
Aug 6, 2025 | 6-K | Report of foreign issuer |
Aug 1, 2025 | 6-K | Report of foreign issuer |
Jul 29, 2025 | 6-K | Report of foreign issuer |
Jul 29, 2025 | 20-F | Annual and transition report of foreign private issuers |
Jul 24, 2025 | 6-K | Report of foreign issuer |
Jul 21, 2025 | 6-K | Report of foreign issuer |
Jul 14, 2025 | 6-K | Report of foreign issuer |